Is Maternal Thyrotropin Releasing Hormone Administration Safe in the Pregnant Woman with Preeclampsia?

Ann S. A. Tan; Chaur-Dong Hsu; Sara Marder; Joshua A. Copel

doi:10.1055/s-2007-994087

American Journal of Perinatology, Table of Contents

Am J Perinatol 1997; 14(1): 5-6
DOI: 10.1055/s-2007-994087

ORIGINAL ARTICLE

Is Maternal Thyrotropin Releasing Hormone Administration Safe in the Pregnant Woman with Preeclampsia?

Ann S.A. Tan, Chaur-Dong Hsu, Sara Marder, Joshua A. Copel

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Yale-New Haven Hospital, Yale University School of Medicine, New Haven, Connecticut

Abstract

ABSTRACT

Maternal intravenous administration of thyrotropin releasing hormone (TRH) is associated with rapid elevations of blood pressure, potentially causative of cerebrovascular accidents. We report a case in which peak blood pressure of 220/120 mm Hg was attained from a baseline of 132/80 mm Hg following TRH administration in a preeclamptic patient.

Keywords

Preeclampsia - thyrotropin releasing hormone (TRH) - blood pressure

Full Text